PVWM
CVS icon

Point View Wealth Management’s CVS Health CVS Stock Holding History

Point View Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$3.23M Sell
47,249
-271
-0.6% -$17.6K 1.31% 5
2020
Q3 		$2.77M Sell
47,520
-2,153
-4% -$134K 1.31% 7
2020
Q2 		$3.23M Buy
49,673
+17
+0% +$1.07K 1.55% 5
2020
Q1 		$2.95M Buy
49,656
+3,077
+7% +$205K 1.61% 4
2019
Q4 		$3.46M Buy
46,579
+1,633
+4% +$115K 1.43% 5
2019
Q3 		$2.83M Buy
44,946
+2,086
+5% +$124K 1.28% 9
2019
Q2 		$2.33M Buy
42,860
+14,085
+49% +$759K 0.99% 19
2019
Q1 		$1.55M Buy
28,775
+5,605
+24% +$346K 0.69% 43
2018
Q4 		$1.52M Buy
23,170
+6,072
+36% +$453K 0.77% 38
2018
Q3 		$1.35M Buy
17,098
+3
+0% +$214 0.6% 49
2018
Q2 		$1.1M Buy
17,095
+1,320
+8% +$87K 0.51% 62
2018
Q1 		$981K Sell
15,775
-968
-6% -$69.5K 0.47% 69
2017
Q4 		$1.21M Buy
16,743
+817
+5% +$59.4K 0.58% 52
2017
Q3 		$1.3M Sell
15,926
-582
-4% -$46K 0.62% 46
2017
Q2 		$1.33M Buy
16,508
+495
+3% +$39.1K 0.65% 44
2017
Q1 		$1.26M Sell
16,013
-37
-0.2% -$2.95K 0.65% 46
2016
Q4 		$1.27M Buy
16,050
+110
+0.7% +$8.9K 0.73% 40
2016
Q3 		$1.42M Sell
15,940
-36
-0.2% -$3.4K 0.84% 29
2016
Q2 		$1.53M Buy
15,976
+21
+0.1% +$2.09K 0.93% 27
2016
Q1 		$1.66M Sell
15,955
-78
-0.5% -$7.58K 1.07% 18
2015
Q4 		$1.57M Sell
16,033
-209
-1% -$20.5K 1.13% 19
2015
Q3 		$1.57M Buy
16,242
+135
+0.8% +$14.2K 1.25% 15
2015
Q2 		$1.69M Buy
16,107
+1
+0% +$102 1.31% 14
2015
Q1 		$1.66M Sell
16,106
-1,751
-10% -$177K 1.28% 15
2014
Q4 		$1.72M Sell
17,857
-812
-4% -$71.5K 1.28% 17
2014
Q3 		$1.49M Sell
18,669
-139
-0.7% -$11K 1.26% 18
2014
Q2 		$1.42M Sell
18,808
-376
-2% -$28.4K 1.23% 19
2014
Q1 		$1.44M Sell
19,184
-497
-3% -$35.1K 1.31% 17
2013
Q4 		$1.41M Buy
+19,681
New +$1.26M 1.34% 16

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point View Wealth Management's CVS Position: Q4 2020 in Review

Point View Wealth Management reduced its CVS Health (CVS) stake by 0.57% in Q4 2020, selling an estimated $17.6K and leaving 47,249 shares worth $3.23M. The position accounts for 1.31% of the portfolio, ranked #5.

Point View Wealth Management first reported a position in CVS in Q4 2013 and has held it in 29 quarters since. The position peaked at $3.46M in Q4 2019. 1,973 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

  • Point View Wealth Management held 47,249 shares of CVS Health worth $3.23M as of Q4 2020.
  • Point View Wealth Management sold 271 CVS Health shares in Q4 2020, an estimated $17.6K.
  • CVS Health made up 1.31% of Point View Wealth Management's portfolio in Q4 2020, its #5 holding.
  • Point View Wealth Management first reported a position in CVS Health in Q4 2013 and has held it in 29 quarters since.
  • Point View Wealth Management's CVS Health position peaked at $3.46M in Q4 2019.
  • 1,973 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Point View Wealth Management's 13F filing for Q4 2020, filed 8 Feb 2021.